Description
List of securities and quantities to be auctioned in demat auction settlement number 802 dated January 21, 2026.
Summary
Bombay Stock Exchange has published the list of securities to be auctioned in demat auction for Settlement No. 802 dated January 21, 2026. The auction includes 138 different scrips with quantities ranging from 1 share to 20,000 shares across various sectors.
Key Points
- Settlement Number: 802
- Date: January 21, 2026
- Total number of scrips involved: 138
- Quantities range from 1 share (multiple scrips) to 20,000 shares (Tilak Venture)
- Covers diverse sectors including banking, steel, pharmaceuticals, infrastructure, mutual funds, and consumer goods
- Notable high-quantity auctions include Tilak Venture (20,000 shares), Boston Bio Sciences (5,000 shares), Rail Vikas Nigam (4,575 shares)
Regulatory Changes
No regulatory changes announced. This is a routine demat auction notification.
Compliance Requirements
- Trading members who have failed to deliver securities in the specified settlement must participate in the auction
- Members must ensure availability of funds/securities for auction settlement
- Auction participants must comply with BSE auction procedures and timelines
- Settlement obligations must be fulfilled as per BSE regulations
Important Dates
- Auction Date: January 21, 2026
- Settlement No: 802
Impact Assessment
This demat auction affects trading members who failed to deliver securities in settlement 802. The impact is localized to specific brokers and their clients who have outstanding delivery obligations. Large quantity auctions for scrips like Tilak Venture (20,000 shares), Boston Bio Sciences (5,000 shares), and Rail Vikas Nigam (4,575 shares) may experience temporary price volatility during the auction process. For investors holding these securities, there may be short-term liquidity and price discovery implications. The auction mechanism ensures settlement integrity and protects the interests of purchasing members.
Impact Justification
Routine demat auction affecting multiple securities with varying quantities. Medium impact as it involves settlement obligations for specific scrips where delivery failures occurred.